Relevance of DMS-III Depressive Subtype and Chronicity of Antidepressant Efficacy in Atypical Depression
Archives of General PsychiatryPublished 1 December 1989
J W Stewart
Citations93
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Atypical depression and longitudinal course of illness may add to the usefulness of DMS-III depressive diagnosis as a predictor of antidepressant response.
Abstract
One hundred ninety-four nonmelancholic depressed outpatients with features of atypical depression took part in a 6-week randomized trial of imipramine hydrochloride, phenelzine sulfate, and placebo. Their courses of illness were also rated for chronicity. Significantly more patients responded to phenelzine (71%) than to imipramine (48%), which benefited significantly more patients than placebo (26%). Both chronicity and DMS-III diagnosis predicted response on several outcome measures. For example, patients with dysthymic disorder responded better to treatment than did those with major depression, suggesting that dysthymic disorder can be treated with medication. Placebo response correlated inversely with chronicity, regardless of DMS-III diagnosis. Atypical depression and longitudinal course of illness may add to the usefulness of DMS-III depressive diagnosis as a predictor of antidepressant response.
Keywords
Medicine
Journal of Neurology Neurosurgery & PsychiatryA RATING SCALE FOR DEPRESSION
32,633 Citations1960M. Hamilton
The present scale has been devised for use only on patients already diagnosed as suffering from affective disorder of depressive type, used for quantifying the results of an interview, and its value depends entirely on the skill of the interviewer in eliciting the necessary information.
Archives of General PsychiatrySeasonal Affective Disorder
2,326 Citations1984Norman E. Rosenthal
Preliminary studies in 11 patients suggest that extending the photoperiod with bright artificial light has an antidepressant effect and sleep recordings in nine depressed patients confirmed the presence of hypersomnia and showed increased sleep latency and reduced slow-wave (delta) sleep.
Archives of General PsychiatryEndogenomorphic Depression
593 Citations1974Donald F. Klein
This report reviews conflicts in delineating the phenomena of depression with an emphasis on the central criterion role of the symptomatic pattern of the nonprecipitated (endogenous) depression.
Archives of General PsychiatryHamilton Depression Rating Scale
428 Citations1981Jean Endicott
The comparative reliability and the validity of the extracted HDRS score as a substitute for a realHDRS score was established and the correlation between the extracted and real HDRS scores was positive and large.
American Journal of Psychiatry"Double depression": superimposition of acute depressive episodes on chronic depressive disorders
363 Citations1982Martín Keller, Robert Shapiro
The authors found that patients withsuperimposed depression relapsed at a significantly higher rate immediately after recovery from the acute episode of depression than did patients without superimposed depression.
Archives of General PsychiatryPrediction of Tricyclic Antidepressant Response
351 Citations1976Robert J. Bielski
Pretreatment urinary 3-methoxy-4-hydroxyphenylglycol levels may some day be useful in predicting to which of these two tricyclic antidepressants a patient will respond.
Archives of General PsychiatryAntidepressant Specificity in Atypical Depression
350 Citations1988Michael R. Liebowitz
The concept of atypical depression as a subtype that is preferentially responsive to monoamine oxidase inhibitors is supported and the superiority of either phenelzine or imipramine to placebo is supported.
Archives of General PsychiatryPhenelzine v Imipramine in Atypical Depression
260 Citations1984Michael R. Liebowitz
Phenelzine was superior to placebo on many measures, while the superiority of imipramine to placebo was confined to several variables, and trends toward superiority on several other measures.
American Journal of Psychiatry"Double depression": two-year follow-up
252 Citations1983Martin B. Keller, Phillip W. Lavori +3 more
The longer the patient continued to suffer from a chronic minor depression after recovering from the major depression, the greater the probability that relapse into another major depression would preempt recovery from the chronic depression.
Archives of General PsychiatryLow Levels and Lack of Predictors of Somatotherapy and Psychotherapy Received by Depressed Patients
231 Citations1986Martin B. Keller
Treatment of patients with nonbipolar major depressive disorders during the first eight weeks after entry into the National Institute of Mental Health-Clinical Research Branch Collaborative Program on the Psychobiology of Depression do not appear to be related to differences in patient characteristics.
Archives of General PsychiatryThe Depressive Personality
208 Citations1972Paul Chodoff
There is enough evidence for depressogenic potential of the socalled oral or dependent personality as described by psychoanalysts, especially in the case of major (manic-depressive) illnesses, to warrant further investigation.
American Journal of PsychiatryPhenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders
197 Citations1988F M Quitkin, Jonathan W. Stewart +8 more
Phenelzine was found to be superior to imipramine and placebo and the size of the drug effect was comparable in patients with full atypical and partial atypicals syndromes.
Archives of General PsychiatryImipramine Treatment for Chronic Depression
177 Citations1988James H. Kocsis
Anti-depressant medication was effective for many moderately severe chronic depressions, which had previously been untreated or undertreated, presumably related to misdiagnosis.
Archives of General PsychiatryPhenelzine and Imipramine in Mood Reactive Depressives
116 Citations1989F M Quitkin, Patrick J. McGrath +8 more
Pharmacologic dissection suggests that atypical symptoms in patients with nonautonomous mood may delineate a qualitatively distinct subgroup.
Psychiatry ResearchSocial functioning in chronic depression: Effect of 6 weeks of antidepressant treatment
89 Citations1988Jonathan W. Stewart, Frederic M. Quitkin +5 more
It is suggested that for some chronically depressed patients, impaired functioning results at least partly from the Axis I mood disorder instead of being entirely attributable to Axis II character pathology.
The British Journal of PsychiatryDouble-Blind Study of Imipramine versus Phenelzine in Melancholias and Dysthymic Disorders
64 Citations1987J. Vallejo, Cristòbal Gastó +2 more
In 32 Dysthymic patients, phenelzine in high doses was found to be superior to imipramine and the clinical implications of these findings are discussed.
Archives of General PsychiatryTreatment Outcome Validation of DSM-III Depressive Subtypes
55 Citations1985Jonathan W. Stewart
Evidence of panic attacks seemed to identify patients who benefited from desipramine therapy, suggesting that the DSM-III hierarchy, which excludes consideration of panic in patients with major depression, may require revision.
Journal of Affective DisordersEfficacy of desipramine in endogenomorphically depressed patients
30 Citations1980Jonathan W. Stewart, Frederic M. Quitkin +6 more
Results suggest that endogenomorphically depressed patients may have a relatively homogeneous catecholamine deficiency, and that presence or absence of a precipitant may be irrelevant in predicting response to tricyclic antidepressants in endogenomorphic depressions.